BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16321440)

  • 1. Dmu expression causes enrichment of MZ B cells, but is non permissive for B cell maturation in Rag2-/- mice even if combined with Bcl-2.
    Wikström I; Bergqvist I; Holmberg D; Forssell J
    Mol Immunol; 2006 Mar; 43(9):1316-24. PubMed ID: 16321440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DH element reading frame selection is influenced by an Ig heavy chain transgene, but not by bcl-2.
    Tarlinton D; Strasser A; McLean M; Basten A
    J Immunol; 1995 Apr; 154(7):3341-50. PubMed ID: 7897217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of Fas cell surface expression during development of T- or B-lymphocyte lineages in normal, scid, and mutant mice lacking or overexpressing p53, bcl-2, or rag-2 genes.
    Li T; Ramirez K; Palacios R
    Cell Growth Differ; 1996 Jan; 7(1):107-14. PubMed ID: 8788039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive Bcl-2 expression during immunoglobulin heavy chain-promoted B cell differentiation expands novel precursor B cells.
    Young F; Mizoguchi E; Bhan AK; Alt FW
    Immunity; 1997 Jan; 6(1):23-33. PubMed ID: 9052834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncated immunoglobulin Dmu causes incomplete developmental progression of RAG-deficient pro-B cells.
    Malynn BA; Shaw AC; Young F; Stewart V; Alt FW
    Mol Immunol; 2002 Jan; 38(7):547-56. PubMed ID: 11750656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice.
    Strasser A; Harris AW; Corcoran LM; Cory S
    Nature; 1994 Mar; 368(6470):457-60. PubMed ID: 8133891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo.
    O'Reilly LA; Harris AW; Tarlinton DM; Corcoran LM; Strasser A
    J Immunol; 1997 Sep; 159(5):2301-11. PubMed ID: 9278319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic exclusion in transgenic mice expressing a heavy chain disease-like human mu protein.
    Corcos D; Iglesias A; Dunda O; Bucchini D; Jami J
    Eur J Immunol; 1991 Nov; 21(11):2711-6. PubMed ID: 1936120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome analysis in primary B lymphoid precursors following induction of the pre-B cell receptor.
    Schuh W; Meister S; Herrmann K; Bradl H; Jäck HM
    Mol Immunol; 2008 Jan; 45(2):362-75. PubMed ID: 17681603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
    Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
    Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of B lymphocyte development by the truncated immunoglobulin heavy chain protein Dmu.
    Tornberg UC; Bergqvist I; Haury M; Holmberg D
    J Exp Med; 1998 Mar; 187(5):703-9. PubMed ID: 9480980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface mu heavy chain signals down-regulation of the V(D)J-recombinase machinery in the absence of surrogate light chain components.
    Galler GR; Mundt C; Parker M; Pelanda R; Mårtensson IL; Winkler TH
    J Exp Med; 2004 Jun; 199(11):1523-32. PubMed ID: 15173209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate-light-chain silencing is not critical for the limitation of pre-B cell expansion but is for the termination of constitutive signaling.
    van Loo PF; Dingjan GM; Maas A; Hendriks RW
    Immunity; 2007 Sep; 27(3):468-80. PubMed ID: 17869135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-fos overexpression in splenic B cells augments development of marginal zone B cells.
    Yamashita K; Sakamoto A; Ohkubo Y; Arima M; Hatano M; Kuroda Y; Tokuhisa T
    Mol Immunol; 2005 Mar; 42(5):617-25. PubMed ID: 15607821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKC eta directs induction of IRF-4 expression and Ig kappa gene rearrangement in pre-BCR signaling pathway.
    Oda A; Ono T; Yamamoto M; Goitsuka R; Kitamura D
    Int Immunol; 2008 Nov; 20(11):1417-26. PubMed ID: 18780722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections.
    Senn BM; López-Macías C; Kalinke U; Lamarre A; Isibasi A; Zinkernagel RM; Hengartner H
    Eur J Immunol; 2003 Apr; 33(4):950-61. PubMed ID: 12672061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization.
    Yu W; Nagaoka H; Jankovic M; Misulovin Z; Suh H; Rolink A; Melchers F; Meffre E; Nussenzweig MC
    Nature; 1999 Aug; 400(6745):682-7. PubMed ID: 10458165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of stereotyped VH81X-{micro}H chains via pre-B cell receptor early in ontogeny and their conservation in adults by marginal zone B cells.
    Kawano Y; Yoshikawa S; Minegishi Y; Karasuyama H
    Int Immunol; 2005 Jul; 17(7):857-67. PubMed ID: 15908445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the bcl-2 gene in mouse B lymphocytic cell lines is differentiation stage specific.
    Gurfinkel N; Unger T; Givol D; Mushinski JF
    Eur J Immunol; 1987 Apr; 17(4):567-70. PubMed ID: 3106072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAG1 and RAG2 in developing rabbit appendix subpopulations.
    Fuschiotti P; Fitts MG; Pospisil R; Weinstein PD; Mage RG
    J Immunol; 1997 Jan; 158(1):55-64. PubMed ID: 8977175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.